|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Sheba Medical Center |
|---|---|
| Information provided by: | Sheba Medical Center |
| ClinicalTrials.gov Identifier: | NCT00717392 |
Purpose
Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. The purpose of the current research is to evaluate the efficacy of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy will show better outcomes than children with the same problems who are not treated with hippotherapy.
| Condition |
|---|
|
Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders |
| Estimated Enrollment: | 40 |
| Study Start Date: | September 2008 |
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Hippotherapy_ADHD
10 children with ADHD who receive hippotherapy
|
|
Hippotherapy_ASD
10 children with ASD who receive hippotherapy
|
|
Control_ADHD
10 children with ADHD who DO NOT receive hippotherapy
|
|
Control_ASD
10 children with ASD who DO NOT receive hippotherapy
|
Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. Most studies that tested hippotherapy were uncontrolled and focused on motor problems, such as cerebral palsy. Today, hippotherapy is used for various developmental problems such as Attention deficit / Hyperactivity disorder (ADHD) and Autism spectrum disorder (ASD), without clear information about its efficacy for these populations.
The purpose of the current research is to evaluate the efficacy of 6 months of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy for 6 months will show better outcomes than children with the same problems who are not treated with hippotherapy.
Assessment:
All questionnaires will be applied at the beginning of the study and after 6 months.
Eligibility| Ages Eligible for Study: | 5 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Hippotherapy subjects will be taken from horseback riding farms. Control subjects will be taken from a tertiary care clinic.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Lidia Gabis, MD | +972-3-5302236 | lidia.gabis@sheba.health.gov.il |
| Contact: Raanan Raz, Ph.D | +972-3-5302236 | Raanan.Raz@sheba.health.gov.il |
| Israel | |
| Weinberg Child Development Center, Sheba Medical Center, Tel-Hashomer | Recruiting |
| Ramat-Gan, Israel | |
| Principal Investigator: Lidia Gabia, MD | |
| Principal Investigator: | Lidia Gabis, MD | Sheba Medical Center |
More Information
| Responsible Party: | Sheba Medical Center ( Lidia Gabis ) |
| Study ID Numbers: | SHEBA-08-5327-LG-CTIL |
| Study First Received: | July 16, 2008 |
| Last Updated: | January 15, 2009 |
| ClinicalTrials.gov Identifier: | NCT00717392 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
ADHD ASD |
|
Child Development Disorders, Pervasive Developmental Disabilities Signs and Symptoms Attention Deficit Disorder with Hyperactivity Mental Disorders Autistic Disorder |
Mental Disorders Diagnosed in Childhood Attention Deficit and Disruptive Behavior Disorders Neurologic Manifestations Hyperkinesis Dyskinesias |
|
Pathologic Processes Disease Nervous System Diseases |
